Bayer Aktiengesellschaft (BAYRY)
USD 4.92
(-2.19%)
USD 4.92
(-2.19%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 37.23 Billion EUR | 10.22% |
| 2022 | 33.78 Billion EUR | -7.39% |
| 2021 | 36.47 Billion EUR | 9.9% |
| 2020 | 33.19 Billion EUR | -10.06% |
| 2019 | 36.9 Billion EUR | -2.12% |
| 2018 | 37.7 Billion EUR | 210.15% |
| 2017 | 12.15 Billion EUR | -20.92% |
| 2016 | 15.37 Billion EUR | -5.86% |
| 2015 | 16.33 Billion EUR | -8.23% |
| 2014 | 17.79 Billion EUR | 252.84% |
| 2013 | 5.04 Billion EUR | -24.78% |
| 2012 | 6.7 Billion EUR | -12.75% |
| 2011 | 7.68 Billion EUR | -19.79% |
| 2010 | 9.58 Billion EUR | -11.9% |
| 2009 | 10.87 Billion EUR | 9.93% |
| 2008 | 9.89 Billion EUR | -22.06% |
| 2007 | 12.69 Billion EUR | 15.05% |
| 2006 | 11.03 Billion EUR | 83.41% |
| 2005 | 6.01 Billion EUR | -15.41% |
| 2004 | 7.11 Billion EUR | 0.17% |
| 2003 | 7.1 Billion EUR | -3.06% |
| 2002 | 7.32 Billion EUR | 138.11% |
| 2001 | 3.07 Billion EUR | 9.48% |
| 2000 | 2.8 Billion EUR | 19.11% |
| 1999 | 2.35 Billion EUR | -1.87% |
| 1998 | 2.4 Billion EUR | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q1 | 37.98 Billion EUR | 2.03% |
| 2024 Q2 | 37.39 Billion EUR | -4.84% |
| 2023 Q4 | 37.23 Billion EUR | -23.13% |
| 2023 Q1 | 47.29 Billion EUR | 40.0% |
| 2023 Q3 | 48.43 Billion EUR | -3.32% |
| 2023 Q2 | 50.09 Billion EUR | 5.92% |
| 2023 FY | 37.23 Billion EUR | 10.22% |
| 2022 Q3 | 53.52 Billion EUR | -0.32% |
| 2022 Q2 | 53.69 Billion EUR | -0.4% |
| 2022 FY | 33.78 Billion EUR | -7.39% |
| 2022 Q1 | 53.9 Billion EUR | 47.78% |
| 2022 Q4 | 33.78 Billion EUR | -36.88% |
| 2021 Q2 | 53.07 Billion EUR | 2.68% |
| 2021 FY | 36.47 Billion EUR | 9.9% |
| 2021 Q3 | 53.34 Billion EUR | 0.51% |
| 2021 Q1 | 51.69 Billion EUR | 55.73% |
| 2021 Q4 | 36.47 Billion EUR | -31.62% |
| 2020 Q2 | 33.94 Billion EUR | -7.78% |
| 2020 Q3 | 50.29 Billion EUR | 48.16% |
| 2020 Q4 | 33.19 Billion EUR | -34.0% |
| 2020 FY | 33.19 Billion EUR | -10.06% |
| 2020 Q1 | 36.81 Billion EUR | -0.26% |
| 2019 Q2 | 36.72 Billion EUR | -3.24% |
| 2019 Q4 | 36.9 Billion EUR | -2.26% |
| 2019 FY | 36.9 Billion EUR | -2.12% |
| 2019 Q3 | 37.76 Billion EUR | 2.83% |
| 2019 Q1 | 37.95 Billion EUR | 0.64% |
| 2018 FY | 37.7 Billion EUR | 210.15% |
| 2018 Q4 | 37.7 Billion EUR | -6.57% |
| 2018 Q3 | 40.35 Billion EUR | -5.25% |
| 2018 Q2 | 42.59 Billion EUR | 247.05% |
| 2018 Q1 | 12.27 Billion EUR | 0.95% |
| 2017 Q2 | 14.16 Billion EUR | -4.19% |
| 2017 Q3 | 12.57 Billion EUR | -11.24% |
| 2017 Q4 | 12.15 Billion EUR | -3.32% |
| 2017 FY | 12.15 Billion EUR | -20.92% |
| 2017 Q1 | 14.78 Billion EUR | -3.82% |
| 2016 FY | 15.37 Billion EUR | -5.86% |
| 2016 Q4 | 15.37 Billion EUR | -6.9% |
| 2016 Q1 | 17.11 Billion EUR | 4.82% |
| 2016 Q3 | 16.51 Billion EUR | 0.16% |
| 2016 Q2 | 16.48 Billion EUR | -3.69% |
| 2015 Q3 | 16.74 Billion EUR | -2.55% |
| 2015 FY | 16.33 Billion EUR | -8.23% |
| 2015 Q4 | 16.33 Billion EUR | -2.44% |
| 2015 Q1 | 16.92 Billion EUR | -4.92% |
| 2015 Q2 | 17.17 Billion EUR | 1.52% |
| 2014 Q4 | 17.79 Billion EUR | 56.09% |
| 2014 Q1 | 8.1 Billion EUR | 60.63% |
| 2014 Q2 | 8 Billion EUR | -1.16% |
| 2014 Q3 | 11.4 Billion EUR | 42.38% |
| 2014 FY | 17.79 Billion EUR | 252.84% |
| 2013 Q3 | 5.8 Billion EUR | -20.6% |
| 2013 Q4 | 5.04 Billion EUR | -13.05% |
| 2013 FY | 5.04 Billion EUR | -24.78% |
| 2013 Q1 | 6.83 Billion EUR | 1.94% |
| 2013 Q2 | 7.3 Billion EUR | 6.88% |
| 2012 Q4 | 6.7 Billion EUR | -5.77% |
| 2012 Q2 | 7.32 Billion EUR | -7.63% |
| 2012 Q3 | 7.11 Billion EUR | -2.77% |
| 2012 Q1 | 7.92 Billion EUR | 3.11% |
| 2012 FY | 6.7 Billion EUR | -12.75% |
| 2011 FY | 7.68 Billion EUR | -19.79% |
| 2011 Q4 | 7.68 Billion EUR | 2.19% |
| 2011 Q3 | 7.52 Billion EUR | 3.72% |
| 2011 Q2 | 7.25 Billion EUR | -23.98% |
| 2011 Q1 | 9.53 Billion EUR | -0.46% |
| 2010 Q3 | 10.36 Billion EUR | -6.1% |
| 2010 FY | 9.58 Billion EUR | -11.9% |
| 2010 Q2 | 11.04 Billion EUR | 3.43% |
| 2010 Q4 | 9.58 Billion EUR | -7.57% |
| 2010 Q1 | 10.67 Billion EUR | -1.85% |
| 2009 Q4 | 10.87 Billion EUR | 0.0% |
| 2009 FY | 10.87 Billion EUR | 9.93% |
| 2008 Q1 | 12.64 Billion EUR | -0.36% |
| 2008 Q2 | 8.92 Billion EUR | -29.44% |
| 2008 FY | 9.89 Billion EUR | -22.06% |
| 2008 Q4 | 9.89 Billion EUR | 5.03% |
| 2008 Q3 | 9.42 Billion EUR | 5.55% |
| 2007 Q2 | 13.64 Billion EUR | -6.69% |
| 2007 FY | 12.69 Billion EUR | 15.05% |
| 2007 Q4 | 12.69 Billion EUR | -8.07% |
| 2007 Q1 | 14.62 Billion EUR | 32.52% |
| 2007 Q3 | 13.8 Billion EUR | 1.22% |
| 2006 Q1 | - EUR | -100.0% |
| 2006 Q4 | 11.03 Billion EUR | -23.55% |
| 2006 Q3 | 14.43 Billion EUR | 0.0% |
| 2006 FY | 11.03 Billion EUR | 83.41% |
| 2006 Q2 | - EUR | 0.0% |
| 2005 Q3 | - EUR | -100.0% |
| 2005 Q4 | 6.01 Billion EUR | 0.0% |
| 2005 FY | 6.01 Billion EUR | -15.41% |
| 2005 Q1 | 6.87 Billion EUR | -3.39% |
| 2005 Q2 | 7.3 Billion EUR | 6.38% |
| 2004 Q3 | 6.69 Billion EUR | 0.52% |
| 2004 Q1 | 7.03 Billion EUR | -0.91% |
| 2004 FY | 7.11 Billion EUR | 0.17% |
| 2004 Q4 | 7.11 Billion EUR | 6.17% |
| 2004 Q2 | 6.66 Billion EUR | -5.27% |
| 2003 FY | 7.1 Billion EUR | -3.06% |
| 2003 Q4 | 7.1 Billion EUR | 0.0% |
| 2003 Q3 | - EUR | 0.0% |
| 2003 Q2 | - EUR | 0.0% |
| 2003 Q1 | - EUR | -100.0% |
| 2002 Q3 | - EUR | 0.0% |
| 2002 Q4 | 7.32 Billion EUR | 0.0% |
| 2002 Q1 | - EUR | -100.0% |
| 2002 FY | 7.32 Billion EUR | 138.11% |
| 2002 Q2 | - EUR | 0.0% |
| 2001 Q2 | - EUR | 0.0% |
| 2001 Q1 | - EUR | 0.0% |
| 2001 Q4 | 3.07 Billion EUR | 0.0% |
| 2001 Q3 | - EUR | 0.0% |
| 2001 FY | 3.07 Billion EUR | 9.48% |
| 2000 FY | 2.8 Billion EUR | 19.11% |
| 1999 FY | 2.35 Billion EUR | -1.87% |
| 1998 FY | 2.4 Billion EUR | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| AstraZeneca PLC | 22.33 Billion USD | -66.71% |
| Bristol-Myers Squibb Company PFD CONV 2 | 38.18 Billion USD | 2.491% |
| CSPC Pharmaceutical Group Limited | 107.05 Million USD | -34677.41% |
| Clarus Therapeutics Holdings, Inc. | - USD | -Infinity% |
| Novartis AG | 20.03 Billion USD | -85.844% |
| PT Kalbe Farma Tbk. | 19.39 Million USD | -191897.729% |